WallStSmart

Medtronic PLC (MDT)vsTrinity Biotech plc (TRIB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 57546% more annual revenue ($35.48B vs $61.55M). MDT leads profitability with a 13.0% profit margin vs -51.6%. TRIB appears more attractively valued with a PEG of 1.30. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

TRIB

Hold

37

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued

Intrinsic value data unavailable for TRIB.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

TRIB1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
18.1%8/10

18.1% revenue growth

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

TRIB4 concerns · Avg: 2.3/10
Market CapQuality
$15.89M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-19.1%2/10

ROE of -19.1% — below average capital efficiency

EPS GrowthGrowth
-77.3%2/10

Earnings declined 77.3%

Free Cash FlowQuality
$-77,1092/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : TRIB

The strongest argument for TRIB centers on Revenue Growth. Revenue growth of 18.1% demonstrates continued momentum. PEG of 1.30 suggests the stock is reasonably priced for its growth.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : TRIB

The primary concerns for TRIB are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

MDT profiles as a value stock while TRIB is a growth play — different risk/reward profiles.

MDT carries more volatility with a beta of 0.73 — expect wider price swings.

TRIB is growing revenue faster at 18.1% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 37/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Trinity Biotech plc

HEALTHCARE · MEDICAL DEVICES · USA

Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments of the diagnostic market in the United States, Africa, Asia and Europe. The company is headquartered in Bray, Ireland.

Want to dig deeper into these stocks?